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Background: We used data from a large international database to assess the incidence and impact of extracerebral
organ dysfunction on prognosis of patients admitted after cardiac arrest (CA).
Methods: This was a sub-analysis of the Intensive Care Over Nations (ICON) database, which contains data from all
adult patients admitted to one of 730 participating intensive care units (ICUs) in 84 countries from 8–18 May 2012,
except admissions for routine postoperative surveillance. For this analysis, patients admitted after CA (defined as
those with “post-anoxic coma” or “cardiac arrest” as the reason for ICU admission) were included. Data were
collected daily in the ICU for a maximum of 28 days; patients were followed up for outcome data until death,
hospital discharge, or a maximum of 60 days in-hospital. Favorable neurological outcome was defined as alive at
hospital discharge with a last available neurological Sequential Organ Failure Assessment (SOFA) subscore of 0–2.
Results: Among the 469 patients admitted after CA, 250 (53 %) had had out-of-hospital CA; 210 (45 %) patients
died in the ICU and 357 (76 %) had an unfavorable neurological outcome. Non-survivors had a higher incidence of
renal (43 vs. 16 %), cardiovascular (56 vs. 45 %), and respiratory (62 vs. 48 %) failure on admission and during the ICU
stay than survivors (all p < 0.05). Similar results were found for patients with unfavorable vs. favorable neurological
outcomes. In multivariable analysis, independent predictors of ICU mortality were renal failure on admission, high
admission Simplified Acute Physiology Score (SAPS) II, high maximum serum lactate levels within the first 24 h after ICU
admission, and development of sepsis. Independent predictors of unfavorable neurological outcome were mechanical
ventilation on admission, high admission SAPS II score, and neurological dysfunction on admission.
Conclusions: In this multicenter cohort, extracerebral organ dysfunction was common in CA patients. Renal failure on
admission was the only extracerebral organ dysfunction independently associated with higher ICU mortality.* Correspondence: jlvincent@intensive.org
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Rates of sudden cardiac arrest (CA) vary around the
globe, but it is estimated that the incidence is around 55
events per 100,000 person-years [1]. Overall outcomes
remain poor, with less than 10 % of patients leaving the
hospital alive with good neurological recovery [1]. Brain
damage, exacerbated by global ischemia-reperfusion in-
jury, is the leading cause of death [2–4]. Therapeutic
hypothermia (TH) has been employed following return
of spontaneous circulation (ROSC) to limit the extent of
brain damage, although concerns remain regarding opti-
mal temperature levels, target populations, and duration
of cooling [5, 6]. The so-called “post-cardiac arrest syn-
drome” links ischemia-reperfusion injury with brain dam-
age, myocardial dysfunction, and a systemic inflammatory
response that has remarkable similarities to that of sepsis
and may result in the development of multi-organ failure
(MOF), regardless of whether or not TH is used [7].
There are limited data available on the extent and
prognostic value of extracerebral organ dysfunction after
CA. In a recent report [8], almost all (96 %) of the 203
patients resuscitated after CA had some degree of organ
dysfunction, in particular cardiovascular and respiratory
impairments; two-thirds of these patients had dysfunc-
tion of at least two extracerebral organ systems. Only al-
terations in the cardiovascular and respiratory systems,
as assessed by Sequential Organ Failure Assessment
(SOFA) subscores, were independently associated with
in-hospital mortality. Renal dysfunction has also been re-
ported as an independent prognostic factor for mortality
among CA survivors [9], although conflicting data have
been reported [10]. There are almost no data on coagu-
lation dysfunction in this setting, and only one study de-
scribed the occurrence of hypoxic hepatitis, but not liver
dysfunction, in 11 % of CA survivors, which was also as-
sociated with increased intensive care unit (ICU) mortal-
ity [11].
Information on whether extracerebral organ dysfunc-
tion influences the outcome of patients after CA could
open new lines of research, in particular related to clin-
ical management and development of strategies to pre-
vent such complications. The objectives of this study
were, therefore, to assess the incidence of extracerebral
organ failure in patients resuscitated from CA and its
impact on prognosis, both in terms of ICU mortality
and neurological outcome. For this purpose, we ana-
lyzed data from a contemporary, international data-
base of ICU patients—the Intensive Care Over Nations
(ICON) audit [12].
Methods
Full details of methodology have been provided previ-
ously [12] and a list of participating ICUs is given in
Additional file 1 (Appendix 1).Participating centers
Participating centers were recruited by open invitation,
through national scientific societies, international meet-
ings, and/or individual contacts. Participation was volun-
tary with no financial reimbursement. The participating
institutions obtained local ethical approval.
Inclusion criteria
Each center prospectively collected data on all adult pa-
tients (>16 years of age) who were admitted to their ICU
from 8–18 May 2012; patients who remained in the ICU
for <24 h (i.e., for routine post-operative surveillance) or
who were readmitted were not included. Data were col-
lected daily during the ICU stay for a maximum of
28 days, using electronic case report forms through a se-
cured web-based platform. Patients were followed up for
outcome data until death or hospital discharge, which-
ever came first. Decisions regarding withdrawal of care
were made according to local practices; patients in
whom a decision was made to withdraw care were con-
sidered in the final analysis.
Data collection
Demographics and comorbid diseases (including chronic
obstructive pulmonary disease, solid or hematologic cancer,
liver cirrhosis, heart failure, acquired immunodeficiency
syndrome, chronic renal failure, immunosuppression, se-
vere malnutrition, and insulin-dependent diabetes mellitus)
were collected on admission. Clinical and laboratory data
for the Simplified Acute Physiology Acore (SAPS) II [13]
and the Acute Physiology and Chronic Health Evaluation
(APACHE) II [14] scores were reported as the worst
values within the first 24 h after ICU admission.
Microbiological and clinical infections were reported
daily. A daily assessment of organ function was per-
formed using the SOFA score [15].
Definitions
Most of the definitions have been provided elsewhere
[12]. Briefly, infection was defined in accordance with
the International Sepsis Forum definitions [16]. Sepsis
was defined as the presence of infection with the con-
comitant occurrence of at least one organ failure (i.e., a
SOFA subscore for the organ in question of >2) [17].
Septic shock was defined as sepsis complicated by car-
diovascular failure. For the purposes of this sub-study,
patients with “post-anoxic coma” or “cardiac arrest”
listed as the reason for ICU admission were considered
as having been admitted after CA. CA was considered to
have occurred out-of-hospital (OHCA) if patients were
admitted through the emergency department and/or by
ambulance; all other patients were considered to have
had an in-hospital CA (IHCA). Patients in whom the
lowest body temperature during the first day after ICU
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TH. At the time of the ICON audit, the targeted
temperature management (TTM) study [6], which sug-
gested similar effects on outcome for a cooling strategy
using 33 °C or 36 °C, had not yet been published and rou-
tine practice was to target a temperature of 32–34 °C [18].
Patients were considered as “comatose” (central nervous
system (CNS)-SOFA >2) or “non-comatose” (CNS-SOFA
0–2) on admission. ICU mortality rates and overall neuro-
logical outcomes were collected: patients who were alive
at hospital discharge and in whom the last recorded CNS-
SOFA subscore was between 0 and 2 (corresponding to a
Glasgow Coma Scale (GCS) score of 10–15) were defined
as having a favorable neurological outcome; other patients
(non-survivors and survivors with CNS-SOFA of 3–4, i.e.,
GCS <10) were defined as having an unfavorable neuro-
logical outcome.
Statistical analysis
Data are expressed as mean ± SD, median (interquartile
range) or count (percentage), as appropriate. For con-
tinuous variables, normality assumption checking was
performed by inspection of residual and normal plots.
Differences between groups were assessed using the ana-
lysis of variance (ANOVA), Kruskal-Wallis test, Student’s
t test, Mann–Whitney test, χ2 test, or Fisher’s exact test,
as appropriate. The occurrence of organ failure was also
analyzed according to the location of the arrest (IHCA
vs. OHCA), the geographical region (Africa, Europe,
Asia, Oceania, and America), and the gross national in-
come (GNI) per person (≤US$4035 was defined as low
and lower-middle income; $4036–$12,475 as upper-
middle income, and >$12,476 as high income) [12]. The
time-courses of each SOFA subscore in survivors and
non-survivors or in patients with favorable or unfavor-
able neurological outcome were analyzed using general-
ized estimating equation models. Multivariable logistic
regression was used to identify independent predictors
of ICU death and of unfavorable neurological outcome.
Variables with p < 0.2 in the univariate analysis were
considered in the multivariable analyses. Colinearity be-
tween variables was excluded prior to modeling. Interac-
tions between explanatory variables were also checked.
The deviance of the logistic regression model and de-
viance and partial residuals were used to check for
model adequacy. All reported p values are two-sided
and p < 0.05 was considered to indicate statistical signifi-
cance. Data were analyzed using IBM® SPSS® Statistics soft-
ware, version 22 for Windows (IBM, Armonk, NY, USA).
Results
Among the 10,069 patients included in the ICON regis-
try, 469 had post-anoxic coma (n = 62) or CA (n = 407)
as the reported reason for ICU admission and were thusconsidered as having had a CA. The mean patient age
was 66 (52–77) years, and 282 (61 %) patients were male
(Table 1). The CA occurred out-of-hospital in 250
(53 %) patients. On admission, the median SAPS II score
was 60 (46–75) and the SOFA score was 10 (7–13); 337
(72 %) patients were comatose. A total of 210 (45 %) pa-
tients died during the ICU stay and 357 (76 %) had an
unfavorable neurological outcome; decisions to limit
therapy were made in 170 (36 %) patients.
Mean arterial pressure, pH, and PaO2/FiO2 ratio on
the first day were lower, and maximal lactate level
higher, in non-survivors than in survivors (Table 1).
Non-survivors also had higher SAPS II and SOFA scores
on admission, and were more frequently treated with va-
sopressors. Similar patterns were found when patients
with favorable and unfavorable neurological outcomes
were compared (Table 1).
Non-survivors had a greater incidence of renal, re-
spiratory, and cardiovascular failure than survivors on
admission (43 vs. 16 %, 56 vs. 45 %, 62 vs. 48 %, respect-
ively; all p < 0.05; Fig. 1) and at any time during the ICU
stay (71 % vs. 50 %, 71 vs. 54 %, 75 vs. 57 %, respectively;
all p < 0.05; Fig. 1). Similar patterns were found in pa-
tients with unfavorable and favorable neurological out-
comes (Additional file 1: Figure S1). Patients with
OHCA had a greater incidence of hematologic failure
than those with IHCA, both on ICU admission (7 % vs.
2 %; p = 0.04) and during the ICU stay (14 % vs. 7 %;
p = 0.009; Additional file 1: Figure S2); the occurrence
of other organ failures was similar. There was considerable
variability in the occurrence of organ failures in different
geographical areas: patients from Oceania had the highest
incidence of hepatic failure on admission, whereas respira-
tory failure was significantly more frequent in patients in
Africa and Europe, and hematologic failure occurred more
frequently in patients in Africa and Asia (Additional file 1:
Figure S3). There were no statistically significant differences
in the incidence of organ failure when patients were ana-
lyzed according to the GNI (Additional file 1: Figure S4).
The time-course of several of the SOFA subscores dif-
fered in survivors and non-survivors. In particular, the
hepatic-SOFA subscore increased over time in the non-
survivors but not in the survivors (p = 0.015; Additional
file 1: Figure S5), whereas CNS- and cardiovascular-
SOFA subscores decreased over time in the survivors
but not in the non-survivors (both p < 0.001; Additional
file 1: Figures S6 and S7). The renal-SOFA subscore did
not change over time in the survivors, but was higher in
the non-survivors and decreased progressively over time
(p < 0.001, Fig. 2). The time-course of respiratory- and
hematologic-SOFA subscores was similar in survivors
and non-survivors (Additional file 1: Figures S8 and S9).
Renal-SOFA subscores decreased over time in patients
with a favorable but not in those with an unfavorable








outcome (n = 97)
Unfavorable neurological
outcome (n = 357)
Age, years 66 (52–77) 65 (52–75) 68 (52–78) 67 (53–75) 66 (52–77)
Male, n (%) 282 (61) 149 (61) 126 (61) 60 (62) 222 (60)
Weight, kg 75 (65–87) 75 (66–90) 71 (61–83) 75 (65–90) 74 (65–85)
OHCA, n (%) 250 (53) 120 (49) 124 (59) 34 (35) 216 (58)
IHCA, n (%) 219 (47) 127 (51) 86 (41) 63 (65) 156 (42)
No co-morbidities, n (%) 209 (44) 101 (41) 108 (51) 49 (51) 163 (44)
COPD/asthma, n (%) 65 (14) 39 (16) 26 (12) 17 (17) 51 (14)
Heart failure, n (%) 72 (15) 30 (12) 42 (20) 10 (10) 62 (17)
Diabetes, n (%) 45 (10) 20 (8) 25 (12) 12 (12) 33 (9)
Cancer, n (%) 38 (8) 18 (7) 20 (10) 10 (10) 28 (8)
Chemotherapy, n (%) 9 (2) 4 (2) 5 (2) 1 (1) 8 (2)
Liver cirrhosis, n (%) 14 (3) 1 (1) 13 (6) 1 (1) 13 (3)
Chronic renal failure, n (%) 50 (11) 21 (9) 29 (14) 10 (10) 40 (11)
HIV, n (%) 1 (0) – 1 (1) – 1 (1)
Corticosteroids, n (%) 14 (3) 6 (2) 8 (4) 1 (1) 13 (3)
Medical admission, n (%) 373 (83) 189 (91) 184 (89) 70 (74) 303 (84)
SAPS II score on admission 60 (46–75) 53 (39–64) 71 (57–81)* 38 (29–49) 65(54–79)*
SOFA score on admission 10 (7–13) 8 (6–11) 12 (9–14)* 6 (3–8) 11(8–13)*
Infections
Infection on admission, n (%) 112 (24) 60 (24) 52 (25) 20 (21) 92 (25)
Infection any time, n (%) 200 (43) 120 (49) 80 (38) 41 (41) 159 (43)
Septic shock on admission, n (%) 75 (16) 40 (16) 35 (17) 11 (11) 64 (17)
Septic shock any time, n (%) 133 (28) 74 (30) 59 (28) 20 (21) 113 (30)
Vasopressors on admission, n (%) 262 (57) 124 (50) 138 (66)* 42 (43) 220 (62)*
Mechanical ventilation on admission, n (%) 408 (87) 205 (83) 203 (97) 67 (69) 341 (92)*
Mechanical ventilation any time, n (%) 425 (91) 211 (85) 204 (97) 71 (73) 354 (95)*
Hemodialysis/CRRT on admission, n (%) 38 (8) 19 (8) 19 (9) 4 (4) 34 (9)
Hemodialysis/CRRT any time, n (%) 103 (23) 59 (24) 44 (21) 17 (17) 86 (23)
MAP maximum on first day, mmHg 99 (87–112) 100 (89–113) 97 (85–111) 100 (88–113) 98 (87–112)
MAP minimum on first day, mmHg 61 (50–70) 63 (55–71) 56 (45–68) 63 (55–79) 60 (49–70)*
pH maximum on first day, mmHg 7.40 (7.30–7.45) 7.41 (7.35–7.46) 7.37 (7.23–7.44)* 7.42 (7.36–7.47) 7.39 (7.28–7.45)*
pH minimum on first day, mmHg 7.25 (7.11–7.35) 7.29 (7.19–7.36) 7.18 (7.05–7.29)* 7.32 (7.23–7.38) 7.23 (7.10–7.33)*
PaCO2 maximum on first day, mmHg 45 (37–57) 44 (36–55) 46 (37–60) 45 (37–53) 45 (36–60)
PaCO2 minimum on first day, mmHg 34 (28–40) 34 (28–40) 33 (27–39) 35 (29–40) 33 (28–40)
PaO2 maximum on first day, mmHg 144 (98–229) 135 (94–197) 149 (101–265) 141 (95–190) 145 (99–234)
PaO2 minimum on first day, mmHg 77 (61–98) 77 (64–94) 75 (57–105) 78 (66–90) 76 (60–100)
PaO2/FiO2 maximum on first day 232 (144–344) 232 (151–337) 233 (132–361) 270 (161–374) 227 (143–343)*
PaO2/FiO2 minimum on first day 195 (132–288) 200 (149–294) 186 (120–285)* 218 (165–300) 192 (124–285)*
Lactate maximum on first day, mmol/L 3.6 (2.0–7.6) 2.6 (1.5–5.5) 5.8 (2.5–10.5)* 2.1 (1.2–5.5) 4.30 (2.3–8)*
ICU stay, days 4 (2–8) 5 (3–10) 3 (1–6)* 4 (2–6) 4 (1–8)
Hospital stay, days 8 (2–20) 17 (8–31) 3 (1–6)* 15 (8–22) 5 (2–16)*
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Table 1 Characteristics of the study population, according to ICU survival and neurological outcome at hospital discharge
(Continued)
Limitation of care, n (%) 170 (36) 40 (16) 126 (61)* 11 (11) 159 (44)*
ICU mortality, n (%) 210 (45) – 210 (100)* – 210 (59)
Hospital mortality, n (%) 247 (54) 37 (15) 210 (100)* 11 (11) 236 (67)*
Values are given as median (interquartile range) unless otherwise stated
Missing values: 12 for mortality; 5 for sex; 36 for weight; 23 for source of admission; 15 for vasopressors on admission; 15 for ICU stay, 16 for hospital stay
*p < 0.05, survivors versus non-survivors; favorable outcome versus unfavorable outcome
COPD chronic obstructive pulmonary disease, CRRT continuous renal replacement therapy, FiO2 fraction of inspired oxygen, HIV human immunodeficiency virus,
ICU intensive care unit, IHCA in-hospital cardiac arrest, MAP mean arterial pressure, OHCA out-of-hospital cardiac arrest, PaO2 partial pressure of oxygen, PaCO2
partial pressure of carbon dioxide, SAPS Simplified Acute Physiology Score, SOFA Sequential Organ Failure Assessment
Fig. 1 Occurrence of extracerebral organ failure on intensive care unit (ICU) admission (upper panel) and during the ICU stay (lower panel) in
survivors and non-survivors. *p < 0.05
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Fig. 2 Time-course of renal-SOFA subscore in survivors and non-survivors (upper panel) and in patients with favorable (FO) and unfavorable neurological
outcome (UO) (lower panel). SOFA Sequential Organ Failure Assessment
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the CNS-SOFA subscore (Additional file 1: Figure S10).
The analysis of other SOFA subscores showed a similar
temporal trend between patients with favorable and un-
favorable neurological outcome (Additional file 1: Figures
S11–S14).
Among the ICU survivors, 150 (57 %) patients had an
unfavorable neurological outcome. Thirty-three (16 %)
of the non-survivors had good neurological function
(CNS-SOFA score of 0–2) before death (Additional file
1: Figure S15); however, the CNS-SOFA score on admis-
sion was also 0–2 in all these patients (0 in 19 patients,
1 in 3 patients and 2 in 11 patients); no patient who was
comatose on admission and eventually died hadimproved neurological function during the ICU stay.
These non-survivors with good neurological function
more frequently had renal failure than did survivors
(p < 0.001 versus survivors with good neurological
function and versus survivors with poor neurological
function); they also more frequently had cardiovascular
failure (p = 0.026) and respiratory failure (p = 0.094) than
the ICU survivors with good neurological function (Fig. 3).
In the multivariable analysis, renal failure on admis-
sion, high SAPS II score, high serum lactate levels within
the first 24 h after ICU admission, and the development
of sepsis were independent predictors of ICU mortality
(Table 2). Mechanical ventilation on admission, high
SAPS II score, and high CNS-SOFA score on admission
Fig. 3 Occurrence of circulatory, respiratory, and renal failure in
patients according to their outcome (alive or dead, with neurological
recovery (CNS+) or persistent neurological impairment (CNS–))
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outcome (Table 2). None of the extracerebral organ fail-
ures occurring during the ICU stay were independently
associated with ICU mortality or neurological outcome.
Discussion
This international observational study showed that pa-
tients with a poor outcome after CA had a higher inci-
dence of renal, cardiovascular, and respiratory failure on
admission or during the ICU stay than did patients with
good outcomes. Renal failure on admission was an inde-
pendent predictor of ICU death, as was the severity of
disease, high serum lactate levels, and the development
of sepsis. However, extracerebral organ failure occurring
later during the ICU stay did not significantly influence
ICU mortality or neurological outcome.
Renal dysfunction has been reported in nearly 50 % of
patients after CA, in particular in patients with pre-Table 2 Multivariable analysis to identify the independent
predictors of ICU mortality and unfavorable outcome
Variable p value OR 95 % CI
Predictors of ICU mortality
SAPS II score on admission <0.001 1.047 1.025–1.069
Lactate max, mEq/L 0.004 1.093 1.029–1.161
Renal failure on admission 0.011 2.413 1.220–4.774
Severe sepsis during ICU stay 0.022 0.537 0.316–0.912
Predictors of unfavorable outcome
SAPS II on admission <0.001 1.107 1.077–1.138
MV on admission 0.020 3.787 1.234–11.628
CNS-SOFA on admission <0.001 4.237 3.097–5.796
CI confidence interval, CNS central nervous system, ICU intensive care unit,
Lactate max maximal lactate levels within the first 24 h after ICU admission,
MV mechanical ventilation, OR odds ratio, SAPS Simplified Acute Physiological
Score, SOFA Sequential Organ Failure Assessmentexisting renal dysfunction, older age, longer duration of
resuscitation, and the presence of shock [9, 10, 19–21].
Severe acute kidney injury (AKI) was associated with sig-
nificantly higher mortality at 30 days after CA in one
study [9], but AKI was not an independent predictor of
mortality or poor neurological outcome in two others
[10, 20]. Interestingly, despite the association of renal
failure on admission with increased mortality, the rate
of renal replacement therapy (RRT) was not different
between any of the groups in our study. It is difficult to
compare these findings as different confounders, including
measured outcomes (e.g., hospital survival vs. neurological
outcome), the use of TH, and the proportion of patients
with OHCA, may have influenced the results. Moreover,
evaluation of the impact of RRT on the prognosis of CA
patients may also be influenced by local practice regarding
renal support; for example, the use of RRT for correction
of electrolyte disturbances and/or fluid overload in pa-
tients without overt AKI may be associated with better re-
covery and outcome than RRT initiated for severe renal
failure. In addition, as a number of patients with extensive
brain injury undergo limitation of life-sustaining therapies,
regardless of the development of AKI, it is not always pos-
sible to assess the impact of AKI per se on outcome. In
our study, renal failure was a more significant determinant
of outcome than cardiovascular or respiratory dysfunction.
Our data differ from those of Roberts et al. [8] who re-
ported that extracerebral organ dysfunction was common
after CA but found that only cardiovascular dysfunction
and altered gas exchange were associated with outcome.
However, that study [8] was conducted in a single US aca-
demic hospital over several years, whereas in our multi-
center international audit, data were collected over a short
time period. Moreover, Roberts et al. [8] did not record
blood lactate levels and we observed that increased lactate
concentrations after CA were significantly associated with
ICU mortality. As high lactate concentrations are primar-
ily a consequence of prolonged CA and/or severe subse-
quent hemodynamic impairment [22–24], lactate can be
considered as an extracerebral variable that is predictive
of poor outcome in these patients. Abnormalities in tissue
perfusion occurring after CA may also potentially contrib-
ute to brain hypoperfusion and development of MOF [7].
Thus, monitoring of lactate in this setting may be of more
value to assess the severity of tissue hypoxia than just
blood pressure or cardiac output. Other studies have also
shown the prognostic value of admission blood lactate
levels after CA and of changes in lactate levels in the
hours after CA [22–25].
In this large database, patients admitted after CA rep-
resented around 5 % of the ICU population, similar to
values reported in other studies [26]. The SAPS II score
was higher in patients with poor neurological outcome
or those who died during their ICU stay than in the
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SAPS and APACHE scores are not good prognostic tools
in patients with CA [27, 28]. Conversely, the highest
extracerebral SOFA score at 72 h after CA was inde-
pendently associated with in-hospital mortality [8]. Ad-
mission factors that have been correlated with an
increased SOFA score after CA include non-shockable
rhythm, the amount of epinephrine used, use of TH, and
elevated stress hormone levels [29]. In particular, the
cardiovascular component of the SOFA score has been
shown to accurately predict outcomes of patients with
CA when combined with neurological examination [30];
our results suggest that the renal component should per-
haps also be considered in prediction models.
Mechanical ventilation was one of the independent pre-
dictors of poor neurological outcome. Sutherasan et al.
showed that high tidal volume and plateau pressure with
lower positive end-expiratory pressure were associated with
the occurrence of severe pulmonary complications during
the ICU stay in CA patients [31], suggesting a potential role
of ventilator settings on outcome. Moreover, patients re-
ceiving mechanical ventilation are more exposed to high
oxygen levels or abnormal carbon dioxide concentrations,
which have been shown to have a significant negative im-
pact on brain recovery after post-anoxic injury [32, 33].
Not surprisingly, the severity of brain dysfunction on
admission also predicted an unfavorable outcome. In a
large cohort of CA patients in Japan, the initial GCS
motor score was significantly associated with neuro-
logical outcome, as were age, bystander cardiopulmonary
resuscitation (CPR), the time from collapse to ROSC,
and pupil size [2]. Initial coma was also one of the most
important determinants of outcome in another large
database of CA patients [30].
Another interesting finding was that 16 % of the patients
who eventually died had relatively preserved cerebral func-
tion during their ICU stay. In recent years, several studies
have focused on identifying markers of poor neurological
outcome as if mortality after resuscitated CA were exclu-
sively associated with lack of neurological recovery [3, 4,
34]. Neurological recovery was often assessed 3 to 6 months
after CA and all non-survivors were considered to have a
poor neurological outcome. However, a significant propor-
tion of CA patients die from protracted shock and MOF
[4], which often occurs early after CA, before any possible
neurological outcome assessment. In our study, patients
with good neurological function after CA died from other
reasons, in particular other organ failures. This finding
highlights the importance of repeated neurological assess-
ment of CA patients during the ICU stay because a single
long-term assessment may underestimate the potential for
neurological recovery in some patients.
This study has several limitations. First, the ICON
database was not designed specifically to record data onpost-CA disease, thus some key variables (e.g., initial
rhythm, time to ROSC, or quality of CPR) were not cap-
tured, which limited the degree of adjustment for outcome
analyses. Second, our cohort included patients with “post-
anoxic coma” and “cardiac arrest” as the reason for ICU
admission; it is possible that patients with cerebral injury
without a CA (e.g., after hanging) may have been included
in the "post-anoxic coma" category. Moreover, the delay
between the occurrence of CA and the presence of neuro-
logical impairment was not available. Third, we focused
on ICU and hospital mortality, but not on longer-term
outcomes. In addition, the use of CNS-SOFA to assess
neurological outcome in CA patients has several limita-
tions and is not as accurate as other scores, e.g., the Ran-
kin scale or the Cerebral Performance Scale (CPC), to
quantify the extent of post-anoxic brain injury. Also, we
could not evaluate cognitive dysfunction, which may re-
flect subtle post-anoxic injury. Fourth, given the substan-
tial differences in post-resuscitation care in the countries
included in the ICON database, patient management, in-
cluding healthcare systems, resources and medical sys-
tems, was probably extremely variable among centers.
Data about specific treatments (e.g., coronary angiog-
raphy) were not available. Decisions regarding withdrawal
of care certainly varied among regions. Nevertheless, this
study is hypothesis-generating and may help to provide a
focus on particular organ dysfunctions that should be ad-
equately described in future prospective studies dealing
with management and prognostication in such patients.
Fifth, data on the duration of hypothermia and potential
complications associated with TH were not available. Data
on the development of fever were also not available. Sixth,
data on “ventilator settings” during mechanical ventilation
were not included in the analysis and we cannot comment
on the roles of tidal volume, spontaneous breathing, and/
or exposure to high-inspired oxygen fraction on the mea-
sured outcomes. Finally, the precise causes of death were
not recorded.
Conclusions
In this multicenter cohort of CA patients, 210 (45 %) pa-
tients died in the ICU and 357 (76 %) had an unfavorable
neurological outcome. Extracerebral organ dysfunction
was common, but renal failure on admission was the only
extracerebral organ dysfunction independently associated
with higher ICU mortality.
Key messages Analysis of this large database revealed that renal,
cardiovascular, and respiratory failure occurring on
admission or during the ICU stay was more common
in patients with an unfavorable outcome than in
those with a favorable outcome.
Nobile et al. Critical Care  (2016) 20:368 Page 9 of 10 Renal failure on admission was the only extracerebral
organ dysfunction associated with ICU mortality.
 Extracerebral organ failure occurring later during
the ICU stay did not significantly influence ICU
mortality or neurological outcome.
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